The Lawyer Asia Pacific 150 is the only research report to provide a ranking of the top 100 independent local firms and top 50 global firms in the region. The report offers critical review of some of the fastest growing firms and their strategies, a country-by-country guide to leading legal advisers and legal services market trends, plus exclusive insight into the current business development opportunities in the Asia Pacific. Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Baker & McKenzie (B&M) partner Stewart Saxe has been forced to resign from his position on the board of Canadian pharmaceutical company Draxis Health after B&M tightened its corporate governance rules.
Since long before most lawyers had even heard of messrs Sarbanes and Oxley, the firm has had a rule in place that required its lawyers to seek consent from the firm’s professional responsibility and practice committee in order to sit on the board of a for-profit company. Now that rule has hardened and directorships are no longer tolerated.
“I think Enron was a watershed event for many different reasons. Although we were already well along the road in stopping lawyers from sitting on the boards of for-profit companies, now standards have tightened in Baker & McKenzie,” commented Saxe.
Saxe had sat on the board of Draxis Health for 17 years. As a labour and employment lawyer, he has advised the company on the implementation of its corporate governance and employee relations policies.
Lawyers from around B&M’s international network sit on the professional responsibility and practice committee, which decides all of the firm’s conflict rules.